Data compiled by Redley Lamar · ChainSifter Intelligence
13Suppliers
7Customers
3Debt Items
4Related Chains
Source-Backed Evidence Depth
enVVeno Medical Corporation (NVNO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
24Total relationships
2Distinct source URLs
7High confidence
0.698Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
enVVeno Medical Corporation Suppliers
Ticker
Name
Confidence
Evidence
ACACIA-RESEARCH-CORPORATION
ACACIA-RESEARCH-CORPORATION
80%
From 2000 to March 2007, Mr. Berman was the Chief Operating Officer and General Counsel of Acacia Research Corporation, where he successfully transitioned the company from being an incubator of inter…
ITUS-CORPORATION
ITUS-CORPORATION
80%
From September 2012 until July 2017, he served as the President, Chief Executive Officer, and a member of the Board of Directors of ITUS Corporation (now called Anixa Biosciences), which at the time …
SUPPLIERS
SUPPLIERS
80%
Our suppliers may encounter problems for a variety of reasons, including unanticipated demand from larger customers, failure to follow specific protocols and procedures, failure to comply with applic…
BIOLASE-INC
BIOLASE-INC
70%
Ms. Bright was the Chief Financial Officer of BIOLASE, Inc., until November 2024 when the company sold substantially all assets to MegaGen Implant Co., LTD.
BLANK-ROME
BLANK-ROME
70%
Mr. Berman started his career at the law firm of Blank Rome.
Reciprocal relationship from NYXH graph: Reciprocal relationship from NVNO graph: Reciprocal relationship from NYXH graph: obtain marketing authorization or certification for a product in a particula…
ADVANTAGE-SOLUTIONS-INC
ADVANTAGE-SOLUTIONS-INC
60%
Previously, Ms. Bright held senior accounting director and controller positions at Advantage Solutions, Inc.
APRIA-HEALTHCARE-GROUP-INC
APRIA-HEALTHCARE-GROUP-INC
60%
Previously, Ms. Bright held senior accounting director and controller positions at Apria Healthcare Group, Inc.
CRUNCH-HOLDINGS-LLC
CRUNCH-HOLDINGS-LLC
60%
Previously, Ms. Bright held senior accounting director and controller positions at Crunch Holdings, LLC.
KELLERMEYER-BERGENSONS-SERVICES
KELLERMEYER-BERGENSONS-SERVICES
60%
was the Corporate Controller at Kellermeyer Bergensons Services from November 2018 to April 2020.
RICHMOND-AMERICAN-HOMES
RICHMOND-AMERICAN-HOMES
60%
Previously, Ms. Bright held senior accounting director and controller positions at Richmond American Homes
SPECTRUM-PHARMACEUTICALS
SPECTRUM-PHARMACEUTICALS
60%
From June 2020 to December 2020, she was consulting as Interim Director of Accounting at Spectrum Pharmaceuticals
THE-ACCOUNTING-FIRM-OF
THE-ACCOUNTING-FIRM-OF
60%
was a Supervising Senior Auditor at the accounting firm of
enVVeno Medical Corporation Customers
Ticker
Name
Confidence
Evidence
MEGAGEN-IMPLANT-CO-LTD
MEGAGEN-IMPLANT-CO-LTD
70%
Ms. Bright was the Chief Financial Officer of BIOLASE, Inc., until November 2024 when the company sold substantially all assets to MegaGen Implant Co., LTD.
METROPOLITAN-WOODWORKS-INC
METROPOLITAN-WOODWORKS-INC
70%
Mr. Gray also currently serves as Chairman and President of Metropolitan Woodworks, Inc., a manufacturer of custom kitchen cabinetry based in North Carolina.
U-S-HOLDINGS-LLC-U-S-IMPLANTS-LLC
U-S-HOLDINGS-LLC-U-S-IMPLANTS-LLC
70%
Following Highmark, Mr. Gray co-founded U.S. Holdings LLC (U.S. Implants LLC.), a national distributor of orthopedic implants, and has served as Vice President since 2009.
MEDICAL-DEVICE-COORDINATION-GROUP
MEDICAL-DEVICE-COORDINATION-GROUP
62%
(e.g. Periodic Safety Update Reports) and device registration, more device specific requirements (e.g. Common Specifications), legal liability for defective devices, etc. The QMS audit under MDR will…
HIGHMARK-BLUE-CROSS-BLUE-SHIELD-DELAWARE
HIGHMARK-BLUE-CROSS-BLUE-SHIELD-DELAWARE
60%
Mr. Gray helped increase revenues to $12.3 billion from $6.9 billion, and helped generate an operating gain of $375 million from an operating loss of $91 million. In addition to being the board chair…
HIGHMARK-BLUE-CROSS-BLUE-SHIELD-PENNSYLVANIA
HIGHMARK-BLUE-CROSS-BLUE-SHIELD-PENNSYLVANIA
60%
Mr. Gray helped increase revenues to $12.3 billion from $6.9 billion, and helped generate an operating gain of $375 million from an operating loss of $91 million. In addition to being the board chair…
HIGHMARK-BLUE-CROSS-BLUE-SHIELD-WEST-VIRGINIA
HIGHMARK-BLUE-CROSS-BLUE-SHIELD-WEST-VIRGINIA
60%
Mr. Gray helped increase revenues to $12.3 billion from $6.9 billion, and helped generate an operating gain of $375 million from an operating loss of $91 million. In addition to being the board chair…
enVVeno Medical Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
NVNO-DEBT-11431
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-12-31.
NVNO-DEBT-11430
Warrants outstanding: 861000000
90%
xbrl warrant detail from xbrl 2025-12-31.
NVNO-DEBT
Debt stack $603,000
90%
Market cache reports total debt of $603,000.
enVVeno Medical Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for enVVeno Medical Corporation.
enVVeno Medical Corporation Ownership
Holder
Name
Confidence
Evidence
NVNO-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 1 tracked holders.
enVVeno Medical Corporation Extended Supply Chain Network
